Exploiting the proteomics revolution in biotechnology: From disease and antibody targets to optimizing bioprocess development

Current Opinion in Biotechnology

Volumn 30, Issue , 2014, Pages 80-86

  Heffner, Kelley M ^a   Hizal, Deniz Baycin ^b   Kumar, Amit ^a,c   Shiloach, Joseph ^c   Zhu, Jie ^b   Bowen, Michael A ^b   Betenbaugh, Michael J ^a  

^a Johns Hopkins University   (United States)

^b MEDIMMUNE   (United States)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTECHNOLOGY; CELL PROLIFERATION; CELLS; CYTOLOGY; ESCHERICHIA COLI; MONOCLONAL ANTIBODIES; RECOMBINANT PROTEINS;

BIOPHARMACEUTICAL DEVELOPMENT; BIOPROCESS DEVELOPMENT; BIOPROCESS OPTIMIZATION; CELL GROWTH REGULATION; COMPARATIVE PROTEOMICS; ESCHERICHIA COLI CELLS; MONOCLONAL ANTIBODIES (MAB); RECOMBINANT PROTEIN PRODUCTIONS; PROTEOMICS;

PROTEOMICS;

MONOCLONAL ANTIBODY; PROTEOME; RECOMBINANT PROTEIN;

BACTERIAL CELL; BIOPROCESS; BIOTECHNOLOGY; CELL GROWTH; CELL MATURATION; CHO CELL LINE; ESCHERICHIA COLI; GROWTH REGULATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DATABASE; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN SYNTHESIS; PROTEIN TARGETING; PROTEOMICS; REVIEW; ACCURACY; CELL CYCLE REGULATION; CULTURE MEDIUM; INTERMETHOD COMPARISON; PROCESS DEVELOPMENT; PROCESS OPTIMIZATION; PROTEIN ANALYSIS; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL ELECTROPHORESIS; ANIMAL; CRICETULUS; METABOLISM; PROCEDURES;

ANIMALS; BIOTECHNOLOGY; CHO CELLS; CRICETULUS; ESCHERICHIA COLI; PROTEOMICS;

EID: 84903638921     PISSN: 09581669     EISSN: 18790429     Source Type: Journal    
DOI: 10.1016/j.copbio.2014.06.006     Document Type: Review

References (44)

1. Peng X., Gong F., Zhao Y., Zhou L., Xie Y., Liao H., Lin H., Li Z., Tang M., Tong A. Comparative proteomic approach identifies Pkm2 and cofilin-1 as potential diagnostic, prognostic, and therapeutic targets for pulmonary adenocarcinoma. PLoS ONE 2011, 6. 10.1371/journal.pone.0027309.
2. PosthumaDeBoer J., Piersma S.R., Pham T.V., van Egmond P.W., Knol J.C., Cleton-Jansen A.M., van Geer M.A., van Beusechem V.W., Kaspers G.J., van Royen B.J., et al. Surface proteomic analysis of osteosarcoma identifies EPHA2 as receptor for targeted drug delivery. Br J Cancer 2013, 109:2142-2154.
3. Frei A.P., Jeon O.Y., Kilcher S., Moest H., Henning L.M., Jost C., Pluckthun A., Mercer J., Aebersold R., Carreira E.M., et al. Direct identification of ligand-receptor interactions on living cells and tissues. Nat Biotechnol 2012, 10:997-1001.
4. Cheung W.C., Beausoleil S.A., Zhang X., Sato S., Schieferl S.M., Wieler J.S., Beaudet J.G., Ramenani R.K., Popova L., Comb M.J., et al. A proteomics approach for the identification and cloning of monoclonal antibodies from serum. Nat Biotechnol 2012, 30:447-452.
5. Wine Y., Boutz D.R., Lavinder J.J., Miklos A.E., Hughes R.A., Hoi K.H., Jung S.T., Horton A.P., Murrin E.M., Ellington A.D., et al. Molecular deconvolution of the monoclonal antibodies that comprise the polyclonal serum response. PNAS 2013, 110:2993-2998.
6. Baycin-Hizal D., Tabb D.L., Chaerkady R., Chen L., Lewis N.E., Nagarajan H., Sarkaria V., Kumar A., Wolozny D., Colao J., et al. Proteomic analysis of Chinese hamster ovary cells. J Proteome Res 2012, 11:5265-5276.
7. Xu X., Nagarajan H., Lewis N.E., Pan S., Cai Z., Liu X., Chen W., Xie M., Wang W., Hammond S., et al. The genomic sequence of the Chinese hamster ovary (CHO)-K1 cell line. Nat Biotechnol 2011, 29:735-741.
8. Lewis N.E., Liu X., Li Y., Nagarajan H., Yerganian G., O'Brien E., Bordbar A., Roth A.M., Rosenbloom J., Bian C., et al. Genomic landscapes of Chinese hamster ovary cell lines as revealed by the Cricetulus griseus draft genome. Nat Biotechnol 2013, 31:759-765.
9. Wei Y.Y., Naderi S., Meshram M., Budman H., Scharer J.M., Ingalls B.P., McConkey B.J. Proteomics analysis of Chinese hamster ovary cells undergoing apoptosis during prolonged cultivation. Cytotechnology 2011, 63:663-677.
10. Ohsfeldt E., Huang S., Baycin-Hizal D., Kristoffersen L., Le T.T., Li E., Hristova K., Betenbaugh M.J. Increased expression of the integral membrane proteins EGFR and FGFR3 in anti-apoptotic Chinese hamster ovary cell lines. Biotechnol Appl Biochem 2012, 59:155-162.
11. Carlage T., Kshirsagar R., Zang L., Janakiraman V., Hincapie M., Lyubarskaya Y., Weiskopf A., Hancock W.S. Analysis of dynamic changes in the proteome of a Bcl-XL overexpressing Chinese hamster ovary cell culture during exponential and stationary phases. Biotechnol Prog 2012, 28:814-823.
12. Baik J.Y., Ha T.K., Kim Y.H., Lee G.M. Proteomic understanding of intracellular responses of recombinant Chinese hamster ovary cells adapted to grow in serum-free suspension culture. Biotechnol Prog 2011, 27:1680-1688.
13. Lim U.M., Yap M.G., Lim Y.P., Goh L., Ng S.K. Identification of autocrine growth factors secreted by CHO cells for applications in single-cell cloning media. J Proteome Res 2013, 12:3496-3510.
14. Slade P.G., Hajivandi M., Bartel C.M., Gorfien S.F. Identifying the CHO secretome using mucin-type O-linked glycosylation and click-chemistry. J Proteome Res 2012, 11:6175-6186.
15. Kim J.Y., Kim Y., Han Y.K., Choi H.S., Kim Y.H., Lee G.M. Proteomic understanding of intracellular responses of recombinant Chinese hamster ovary cells cultivated in serum-free medium supplemented with hydrosylates. Appl Micrbiol Biotechnol 2011, 89:1917-1928.
16. Kang S., Ren D., Xiao G., Daris K., Buck L., Enyenihi A.A., Zubarev R., Bondarenko P.V., Deshpande R. Cell line profiling to improve monoclonal antibody production. Biotechnol Bioeng 2013, [Epub ahead of print].
17. Dorai H., Liu S., Yao X., Wang Y., Tekindemir U., Lewis M.J., Wu S., Hancock W. Proteomic analysis of bioreactor cultures of an antibody expressing CHO-GS cell line that promotes high productivity. J Proteomics Bioinform 2013, 6:99-108.
18. Meleady P., Doolan P., Henry M., Barron N., Keenan J., O'Sullivan F., Clarke C., Gammell P., Melville M.W., Leonard M., et al. Sustained productivity in recombinant Chinese hamster ovary (CHO) cell lines: proteome analysis of the molecular basis for a process-related phenotype. BMC Biotechnol 2011, 11:78.
19. Valente K.N., Choe L.H., Lenhoff A.M., Lee K.H. Optimization of protein sample preparation for two-dimensional electrophoresis. Electrophoresis 2012, 33:1947-1950.
20. Valente K.N., Schaefer A.K., Kempton H.R., Lenhoff A.M., Lee K.H. Recovery of Chinese hamster ovary host cell proteins for proteomic analysis. Biotechnol J 2014, 9:87-99.
21. Bonner M.K., Poole D.S., Xu T., Sarkeshik A., Yates J.R., Skop A.R. Mitotic spindle proteomics in Chinese hamster ovary cells. PLoS ONE 2011, 6. 10.1371/journal.pone.0020489.
22. Blattner F.R., Plunkett G., Bloch C.A., Perna N.T., Burland V., Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F., et al. The complete genome sequence of Escherichia coli K-12. Science 1997, 277:1453-1460.
23. Butland G., Peregrin-Alvarez J.M., Li J., Yang W., Yang X., Canadien V., Starostine A., Richards D., Beattie B., Krogan N., et al. Interaction network containing conserved and essential protein complexes in Escherichia coli. Nature 2005, 433:531-537.
24. Lockhart D.J., Winzeler E.A. Genomics, gene expression and DNA arrays. Nature 2000, 405:827-836.
25. Nielsen J., Olsson L. An expanded role for microbial physiology in metabolic engineering and functional genomics: moving towards systems biology. FEMS Yeast Res 2002, 2:175-181.
26. Yoon S.H., Han M.J., Lee S.Y., Jeong K.J., Yoo J.S. Combined transcriptome and proteome analysis of Escherichia coli during high cell density culture. Biotechnol Bioeng 2003, 81:753-767.
27. Pandey A., Mann M. Proteomics to study genes and genomes. Nature 2000, 405:837-846.
28. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
29. Ramachandran B., Dikshit K.L., Dharmalingam K. Recombinant E. coli expressing Vitreoscilla haemoglobin prefers aerobic metabolism under microaerobic conditions: a proteome-level study. J Biosci 2012, 37:617-633.
30. Hemmerlin A., Tritsch D., Hammann P., Rohmer M., Bach T.J. Profiling of defense responses in Escherichia coli treated with fosmidomycin. Biochimie 2013, [Epub ahead of print].
31. Rothmann M., Niessen S., Haushalter R.W., Cravatt B.F., Burkart M.D. Resin-based investigation of acyl carrier protein interaction networks in Escherichia coli. Bioorg Med Chem 2012, 20:667-671.
32. Mikita N., Cheng I., Fishovitz J., Huang J., Lee I. Processive degradation of unstructured protein by Escherichia coli Lon occurs via the slow, sequential delivery of multiple scissile sites followed by rapid and synchronized peptide bond cleavage events. Biochemistry 2013, 52:5629-5630.
33. Wu Q., Yang A., Zou W., Duan Z., Liu J., Chen J., Liu L. Transcriptional engineering of Escherichia coli K4 for fructosylated chondroitin production. Biotechnol Prog 2013, [Epub ahead of print].
34. Sjodin M.O., Wetterhall M., Kultima K., Artemenko K. Comparative study of label and label-free techniques using shotgun proteomics for relative protein quantification. J Chromatogr B Analyt Technol Biomed Life Sci 2013, 928:83-92.
35. Woodruff L.B., Pandhal J., Ow S.Y., Karimpour-Fard A., Weiss S.J., et al. Genome-scale identification and characterization of ethanol tolerance genes in Escherichia coli. Metab Eng 2013, 15:124-133.
36. Ping L., Zhang H., Zhai L., Dammer E.B., Duong D.M., Li N., Yan Z., Wu J., Xu P. Quantitative proteomics reveals significant changes in cell shape and an energy shift after IPTG induction via an optimized SILAC approach for Escherichia coli. J Proteome Res 2013, 12:5978-5980.
37. Hersch S.J., Wang M., Zou S.B., Moon K.M., Foster L.J., Ibba M., Navarre W.W. Divergent protein motifs direct elongation factor P-mediated translational regulation in Salmonella enterica and Escherichia coli. mBio 2013, 4. 10.1128/mBio.00180-13.
38. Soares N.C., Spat P., Krug K., Macek B. Global dynamics of the Escherichia coli proteome and phosphoproteome during growth in minimal medium. J Proteome Res 2013, 12:2611-2621.
39. Mann M. Functional and quantitative proteomics using SILAC. Nat Rev Mol Cell Biol 2006, 7:952-958.
40. Shen Y., Senzer N.N., Nemunaitis J.J. Use of proteomics analysis for molecular precision approaches in cancer therapy. Drug Target Insights 2008, 3:55-66.
41. Gafken P.R., Lampe P.D. Methodologies for characterizing phosphoproteins by mass spectrometry. Cell Commun Adhes 2006, 13:249-262.
42. Aggarwal K., Choe L.H., Lee K.H. Shotgun proteomics using the iTRAQ isobaric tags. Brief Funct Genomic Proteomic 2006, 5:112-120.
43. Haynes P.A., Yates J.R. Proteome profiling - pitfalls and progress. Yeast 2000, 17:81-87.
44. Malinowska A., Kistowski M., Bakun M., Rubel T., Tkaczyk M., Mierzejewska J., Dadlez M. Diffprot - software for non-parametric statistical analysis of differential proteomics data. J Proteomics 2012, 75:4062-4070.